EEU - pharmacokinetic equation??? [Power / Sample Size]

posted by mittyri – Russia, 2017-12-29 14:11 (1062 d 09:32 ago) – Posting: # 18126
Views: 27,144

Hi Yura,

» So I understand: imagine the power analysis and draw a conclusion (at low power) that since bioequivalence is established, a posteriori power rating does not affect the findings of the study
Yep. Once again: to be lucky is not a crime :-D
and vice versa: if the post-hoc power is -> 100%, you're a hero even if the study was overpowered de facto (i.e. CI [0.98-1.03]).

» More interesting question: the pharmacokinetic equation and its analysis ... :confused:
Good question! Next question!
Seems like they are interested in PK model which is not permitted. No clue so far :-|

Kind regards,

Complete thread:

 Admin contact
21,210 posts in 4,426 threads, 1,481 registered users;
online 15 (0 registered, 15 guests [including 6 identified bots]).
Forum time: Wednesday 23:44 CET (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz